The Israeli Supreme Court’s landmark Sanofi v. Unipharm decision establishes crucial precedent on patent applicant duties and unjust enrichment remedies. This ruling demonstrates how misleading patent authorities can result in competitors claiming the deceiving party’s profits, fundamentally reshaping patent prosecution strategies.
Read our comprehensive analysis on Lexology.
